Evidence map›Paper›PMID 42146957›Full record

ArticleRomanian journal of ophthalmology

MOGAD-Associated Recurrent Optic Neuritis Unresponsive to Corticosteroids: Clinical, Visual Field, and OCT Correlation.

Cansu Kostakoğlu Duman, Büşra Gülhan, Yelda Yıldız Taşçı, Gönül Vural

Abstract readCase Reports
In one paragraph

Article in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cansu Kostakoğlu DumanDepartment of Neurology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey.
Büşra GülhanDepartment of Ophthalmology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey.
Yelda Yıldız TaşçıDepartment of Ophthalmology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey.
Gönül VuralDepartment of Neurology, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune demyelinating disorder. In adults, optic neuritis is the most common initial manifestation. Case presentation: We report the case of a 23-year-old woman presenting with right eye vision loss and severe optic disc edema. The condition was unresponsive to intravenous corticosteroids. Plasmapheresis led to marked improvement. Two months later, a second episode occurred in the left eye, despite ongoing steroid therapy. Investigations: Initial brain and orbital MRI were normal. Optical coherence tomography (OCT) showed increased RNFL thickness in the acute phase and progressive thinning during follow-up. Anti-MOG antibodies were detected at a 1:100 titer in serum, confirming the diagnosis. Treatment and outcome: The patient was treated with plasmapheresis, oral steroids, and azathioprine during the first attack. After the second relapse, rituximab was initiated. The patient achieved visual recovery and has remained relapse-free for two years. Conclusion: Corticosteroid-unresponsive recurrent optic neuritis should prompt evaluation for MOGAD, especially in the presence of bilateral involvement and optic disc edema. OCT is valuable for monitoring disease activity and structural damage.

Indexed as

GlucocorticoidsMyelin-Oligodendrocyte GlycoproteinMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseOptic NeuritisTomography, Optical CoherenceVisual AcuityVisual FieldsFemaleHumansMagnetic Resonance ImagingPlasmapheresisRecurrenceYoung AdultGlucocorticoidsMyelin-Oligodendrocyte GlycoproteinBCVA = Best-Corrected Visual AcuityCRION = Chronic Relapsing Inflammatory Optic NeuropathyCSF = Cerebrospinal Fluiddemyelinating diseasedifferential diagnosisIVIG = Intravenous ImmunoglobulinIV = IntravenousMOGAD = Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseMOG = Myelin Oligodendrocyte GlycoproteinMRI = Magnetic Resonance ImagingMS = Multiple Sclerosismyelin oligodendrocyte glycoproteinNMOSD = Neuromyelitis Optica Spectrum DisorderOCB = Oligoclonal BandsOCT = Optical Coherence TomographyOD = Optic DiscON = Optic Neuritisoptic neuritisRNFL = Retinal Nerve Fiber LayerVEP = Visual Evoked Potential

Identifiers

PMID42146957
PMCPMC13178750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.